UBS AM’s Genetron Holdings Limited ADS GTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-11,236
Closed -$73.8K 2803
2022
Q1
$73.8K Hold
11,236
﹤0.01% 2751
2021
Q4
$206K Sell
11,236
-7,920
-41% -$263K ﹤0.01% 2757
2021
Q3
$796K Sell
19,156
-59,361
-76% -$2.73M ﹤0.01% 2280
2021
Q2
$4.74M Buy
78,517
+2,069
+3% +$128K ﹤0.01% 1397
2021
Q1
$4.92M Sell
76,448
-304,752
-80% -$20.9M ﹤0.01% 1347
2020
Q4
$16M Sell
381,200
-4,200
-1% -$152K 0.01% 903
2020
Q3
$13.8M Sell
385,400
-22,933
-6% -$882K 0.01% 863
2020
Q2
$14.8M Buy
+408,333
New +$16.6M 0.01% 821

Other funds holding GTH

UBS AM's GTH Position: Q2 2022 in Review

UBS AM sold out of Genetron Holdings Limited ADS (GTH) in Q2 2022, closing a stake of 11,236 shares — an estimated $73.8K sold.

UBS AM first reported a position in GTH in Q2 2020 and held it in 8 quarters. The position peaked at $16M in Q4 2020. 34 funds tracked by Wall St. Rank hold GTH as of Q2 2022.

  • UBS AM reported no remaining Genetron Holdings Limited ADS position as of Q2 2022 after selling out during the quarter.
  • UBS AM sold 11,236 Genetron Holdings Limited ADS shares in Q2 2022, an estimated $73.8K.
  • UBS AM first reported a position in Genetron Holdings Limited ADS in Q2 2020 and held it in 8 quarters.
  • UBS AM's Genetron Holdings Limited ADS position peaked at $16M in Q4 2020.
  • 34 funds tracked by Wall St. Rank held Genetron Holdings Limited ADS as of Q2 2022.

Based on UBS AM's 13F filing for Q2 2022, filed 12 Aug 2022.